Gracia Rizka Pasfica, Nur Ghaniaviyanto Ramadhan, Faisal Dharma Adhinata
{"title":"1D-Convnet Model for Detection of Antidepressant Drugs","authors":"Gracia Rizka Pasfica, Nur Ghaniaviyanto Ramadhan, Faisal Dharma Adhinata","doi":"10.1109/CyberneticsCom55287.2022.9865476","DOIUrl":null,"url":null,"abstract":"A drug is a substance or mixture of materials to be used in determining the diagnosis, preventing, reducing, eliminating, curing disease or symptoms of disease, bodily or spiritual injury or disorder in humans or animals, including to beautify the body or parts of the human body. Problems begin to arise when a patient is wrong in consuming the target drug used, which is not by the type of disease suffered. For example, suppose a person suffers from a psychological disorder that requires taking different types of drugs, if it turns out that the type of drug consumed is not by the disease, it is very dangerous. This problem is certainly very dangerous because it can cause death for those who consume it. Currently, many researchers are using the deep learning Convolutional Neural Network (CNN) model for drug detection problems. The CNN model has a higher level, namely 1D-Convolutional Neural Network (1D-Convnet) which is still rarely used for drug detection problems. So, the purpose of this study was to detect the classification of atypical antidepressants and SSRIs antidepressants using a deep learning model of the 1D-Convolutional Network (1D-Convnet) type. The results obtained using this model are 98.3% with the most influential parameter, namely dropout. The proposed research model also produces higher accuracy than the Naive Bayes supervised learning model.","PeriodicalId":178279,"journal":{"name":"2022 IEEE International Conference on Cybernetics and Computational Intelligence (CyberneticsCom)","volume":"120 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2022 IEEE International Conference on Cybernetics and Computational Intelligence (CyberneticsCom)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/CyberneticsCom55287.2022.9865476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
A drug is a substance or mixture of materials to be used in determining the diagnosis, preventing, reducing, eliminating, curing disease or symptoms of disease, bodily or spiritual injury or disorder in humans or animals, including to beautify the body or parts of the human body. Problems begin to arise when a patient is wrong in consuming the target drug used, which is not by the type of disease suffered. For example, suppose a person suffers from a psychological disorder that requires taking different types of drugs, if it turns out that the type of drug consumed is not by the disease, it is very dangerous. This problem is certainly very dangerous because it can cause death for those who consume it. Currently, many researchers are using the deep learning Convolutional Neural Network (CNN) model for drug detection problems. The CNN model has a higher level, namely 1D-Convolutional Neural Network (1D-Convnet) which is still rarely used for drug detection problems. So, the purpose of this study was to detect the classification of atypical antidepressants and SSRIs antidepressants using a deep learning model of the 1D-Convolutional Network (1D-Convnet) type. The results obtained using this model are 98.3% with the most influential parameter, namely dropout. The proposed research model also produces higher accuracy than the Naive Bayes supervised learning model.